2. 筋萎縮性側索硬化症 Amyotrophic lateral sclerosis Clinical trials / Disease details

臨床試験数 : 645 / 薬物数 : 589 - (DrugBank : 163) / 標的遺伝子数 : 150 - 標的パスウェイ数 : 225

5 trials found

diseases per page:

Showing 1 to 5 of 5 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2014-002228-28-IT (EUCTR)	01/09/2014	12/06/2014	STEMALS-II	A double blind, placebo controlled, parallel groups, multicenter study on filgrastimin amyotrophic l ...	Amyotrophic lateral sclerosis (ALS) is a severe progressive neurological disorder characterized by a ...	Trade Name: TEVAGRASTIM Product Name: filgrastim Trade Name: MANNITOLO 18%LDB Product Name: MANNITOLO 1 ...	Università degli Studi di Torino e Azienda Ospedaliera Città della Salute e della Scienza di Torino	NULL	Not Recruiting			Female: yes Male: yes	90	Phase 2	Italy
2	NCT02236065 (ClinicalTrials.gov)	August 2014	8/9/2014	Combination Therapy of Cord Blood and G-CSFfor Patients With Brain Injury or Neurodegenerative Disor ...	A Pilot Study of Combination Therapy of Allogeneic Umbilical Cord Blood and Granulocyte-colony Stimu ...	Brain Injury;Cerebral Palsy;Amyotrophic Lateral Sclerosis;Parkinson's Disease	Procedure: Umbilical cord blood therapy;Biological: Filgrastim	MinYoung Kim, M.D.	NULL	Completed	19 Years	75 Years	All	10	N/A	Korea, Republic of
3	NCT01825551 (ClinicalTrials.gov)	November 2012	13/3/2013	The Effect of GCSF in the Treatment of ALS Patients	The Effect of Granulocyte Colony Stimulating Factor(GCSF) in the Treatment of Amyotrophic Lateral Sc ...	Amyotrophic Lateral Sclerosis	Drug: Granulocyte Colony Stimulating Factor;Drug: Placebo	Tehran University of Medical Sciences	NULL	Completed	18 Years	85 Years	Both	40	Phase 2/Phase 3	Iran, Islamic Republic of
4	NCT00397423 (ClinicalTrials.gov)	December 2006	8/11/2006	G-CSF Treatment for Amyotrophic Lateral Sclerosis: A RCT Study Assessing Clinical Response	Granulocyte-Colony Stimulating Factor Treatment for Amyotrophic Lateral Sclerosis: A Randomized Cont ...	Amyotrophic Lateral Sclerosis	Drug: Granulocyte Colony Stimulating Factor;Drug: NS	Peking University	NULL	Completed	18 Years	65 Years	Both	40	Phase 2	China
5	NCT00298597 (ClinicalTrials.gov)	March 2006	1/3/2006	Influence of G-CSF and EPO on Associative Learning and Motor Skills	Influence of G-CSF and EPO on Associative Learning and Motor Skills	Chronic Stroke;Amyotrophic Lateral Sclerosis	Drug: granulocyte - colony stimulating factor (G-CSF);Drug: erythropoetin (EPO)	University Hospital Muenster	NULL	Completed	18 Years	N/A	Both	180	Phase 2	Germany

First Previous1Next Last